Barry A. Borlaug, M.D., is a consultant in the Division of Circulatory Failure, Department of Cardiovascular Medicine, with a joint appointment in the Division of Interventional Cardiology. Dr. Borlaug also serves as Chair of Cardiovascular Research at Mayo Clinic Rochester. He joined the staff of Mayo Clinic in 2006 and holds the academic rank of professor of medicine, Mayo Clinic College of Medicine and Science. He is the Endowed William J. and Sharon A. Schoen Professor of Cardiology.

Dr. Borlaug is an invasive cardiologist who specializes in treating patients with congestive heart failure. He conducts cardiac catheterization procedures, with a special interest in comprehensive invasive hemodynamic assessment. His research interests are focused on the mechanisms, diagnosis and treatment of heart failure — particularly heart failure with preserved ejection fraction. His team is pursuing several clinical studies examining which abnormalities contribute to functional limitation and symptoms of heart failure. Dr. Borlaug’s lab also conducts clinical trials seeking to identify novel therapies to improve functional status and long-term outcomes in patients with heart failure. His research is funded by the National Heart, Lung and Blood Institute, the US Department of Defense, and industry grants. He serves in steering committee leadership roles for multicenter industry-sponsored trials in addition to his federally funded and foundationally funded studies.  Dr. Borlaug has published over 600 peer-reviewed articles as well as multiple book chapters and abstracts. Dr. Borlaug has a long track record of mentorship, with over 50 current or prior trainees, and currently serves as Program Director for the Mayo Clinic Cardiovascular NIH-funded T32 training grant.